A randomized, prospective comparison of allogeneic bone marrow and peripheral blood progenitor cell transplantation in the treatment of hematologic malignancies: An update [5]

Haematologica

Volumn 86, Issue 6, 2001, Pages 665-666

  Vigorito, A C ^a   Marques J F C , Jr ^a   Aranha, F J P ^a   Oliveira, G B ^a   Miranda, E C M ^a   De Souza, C A ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

BMT; Peripheral blood progenitor cells; Transplantation

Indexed keywords

RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; APHERESIS; CELL TRANSPLANTATION; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GRAFT VERSUS HOST REACTION; HEMATOLOGIC DISEASE; HLA SYSTEM; HUMAN; LETTER; MAJOR CLINICAL STUDY; MALE; PHASE 3 CLINICAL TRIAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; STEM CELL;

ADOLESCENT; ADULT; BONE MARROW TRANSPLANTATION; CHILD; FEMALE; GRAFT VS HOST DISEASE; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 0034951037     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (8)

1. Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation
2. Allogeneic peripheral blood stem cell transplantation may be associated with a high risk of chronic graft-versus-host disease
3. High incidence of chronic GVHD after allogeneic peripheral blood progenitor cell transplantation from matched related donors
4. 100 HLA-identical allogeneic blood stem transplantations. The M.D. Anderson cancer experience
5. High incidence of chronic GVHD after primary allogeneic peripheral blood stem cell transplantation in patients with hematologic malignancies
6. Incidence of acute and chronic GVHD after allogeneic peripheral blood stem cell and bone marrow transplantation: A meta-analysis
7. A randomised, prospective comparison of allogeneic bone marrow and peripheral blood progenitor cell transplantation in the treatment of haematological malignancies
8. Quality of life in randomised patients treated with allogeneic BM or PBPC transplantation affected by malignant haematological diseases